What is Agilent Technologies' operating income?

Agilent Technologies' total operating income in 2025 was $1.48 billion, based on the following breakdown: Total Gross Profit: $3.64 billion Total Operating Expenses: $2.16 billion

Agilent Technologies (A) Financials

$144.79 -2.06 (-1.40%)

Closing price 03:59 PM Eastern

Extended Trading

$144.59 -0.19 (-0.13%)

As of 07:58 PM Eastern

Compare

Annual Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Net Income / (Loss) Attributable to Common Shareholders	401	462	684	316	1,071	719	1,210	1,254	1,240	1,289	1,303
Consolidated Net Income / (Loss)	401	462	684	316	1,071	719	1,210	1,254	1,240	1,289	1,303
Net Income / (Loss) Continuing Operations	438	462	684	316	1,071	719	1,210	1,254	1,240	1,289	1,303
Total Pre-Tax Income	480	544	803	946	919	842	1,360	1,504	1,339	1,521	1,435
Total Operating Income	522	615	807	904	941	846	1,347	1,618	1,350	1,488	1,479
Total Gross Profit	2,041	2,197	2,399	2,680	2,805	2,837	3,407	3,722	3,465	3,535	3,643
Total Revenue	4,038	4,202	4,472	4,914	5,163	5,339	6,319	6,848	6,833	6,510	6,948
Operating Revenue	4,038	4,202	4,472	4,914	5,163	5,339	6,319	6,848	6,833	6,510	6,948
Total Cost of Revenue	1,997	2,005	2,073	2,234	2,358	2,502	2,912	3,126	3,368	2,975	3,305
Operating Cost of Revenue	1,997	2,005	2,073	2,234	2,358	2,502	2,912	3,126	3,368	2,975	3,305
Total Operating Expenses	1,519	1,582	1,592	1,776	1,864	1,991	2,060	2,104	2,115	2,047	2,164
Selling, General & Admin Expense	1,189	1,253	1,251	1,389	1,460	1,496	1,619	1,637	1,634	1,568	1,709
Research & Development Expense	330	329	341	387	404	495	441	467	481	479	455
Total Other Income / (Expense), net	-42	-71	-4.00	42	-22	-4.00	13	-114	-11	33	-44
Interest Expense	66	72	79	75	74	78	81	84	95	96	112
Interest & Investment Income	7.00	11	22	38	36	8.00	2.00	9.00	51	80	62
Other Income / (Expense), net	17	-10	53	79	16	66	92	-39	33	49	6.00
Income Tax Expense	42	82	119	630	-152	123	150	250	99	232	132
Basic Earnings per Share	$1.20	$1.42	$2.12	$0.98	$3.41	$2.33	$3.98	$4.19	$4.22	$4.44	$4.59
Weighted Average Basic Shares Outstanding	333M	326M	322M	321M	314M	309M	304M	299M	294M	290M	284M
Diluted Earnings per Share	$1.20	$1.40	$2.10	$0.97	$3.37	$2.30	$3.94	$4.18	$4.19	$4.43	$4.57
Weighted Average Diluted Shares Outstanding	335M	329M	326M	325M	318M	312M	307M	300M	296M	291M	285M
Weighted Average Basic & Diluted Shares Outstanding	334.20M	325.40M	322.60M	322.40M	310.18M	306.85M	302.00M	296.07M	293.00M	285.60M	283.50M
Cash Dividends to Common per Share	$0.40	$0.46	$0.53	$0.60	$0.66	$0.72	$0.78	$0.84	$0.90	$0.94	$0.99

This table shows Agilent Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026	7/31/2026
Net Income / (Loss) Attributable to Common Shareholders	348	308	282	351	318	215	336	434	305	339	362
Consolidated Net Income / (Loss)	348	308	282	351	318	215	336	434	305	339	362
Net Income / (Loss) Continuing Operations	348	308	282	351	318	215	336	434	305	339	362
Total Pre-Tax Income	403	374	343	401	367	260	366	442	364	408	444
Total Operating Income	384	363	333	408	376	300	360	443	353	399	444
Total Gross Profit	908	856	855	916	899	866	888	990	946	990	1,042
Total Revenue	1,658	1,573	1,578	1,701	1,681	1,668	1,738	1,861	1,798	1,835	1,878
Operating Revenue	1,658	1,573	1,578	1,701	1,681	1,668	1,738	1,861	1,798	1,835	1,878
Total Cost of Revenue	750	717	723	785	782	802	850	871	852	845	836
Operating Cost of Revenue	750	717	723	785	782	802	850	871	852	845	836
Total Operating Expenses	524	493	522	508	523	566	528	547	593	591	598
Selling, General & Admin Expense	396	380	395	397	410	454	417	428	476	465	475
Research & Development Expense	128	113	127	111	113	112	111	119	117	126	123
Total Other Income / (Expense), net	19	11	10	-7.00	-9.00	-40	6.00	-1.00	11	9.00	0.00
Interest Expense	22	20	22	32	28	29	28	27	25	25	29
Interest & Investment Income	18	19	19	24	15	14	16	17	15	13	15
Other Income / (Expense), net	23	12	13	1.00	4.00	-25	18	9.00	21	21	14
Income Tax Expense	55	66	61	50	49	45	30	8.00	59	69	82
Basic Earnings per Share	$1.19	$1.05	$0.97	$1.23	$1.12	$0.75	$1.18	$1.54	$1.08	$1.20	$1.28
Weighted Average Basic Shares Outstanding	293M	293M	290M	290M	285M	285M	284M	284M	283M	282M	282M
Diluted Earnings per Share	$1.18	$1.05	$0.97	$1.23	$1.11	$0.75	$1.18	$1.53	$1.07	$1.20	$1.28
Weighted Average Diluted Shares Outstanding	294M	293M	291M	291M	287M	285M	285M	285M	284M	283M	283M
Weighted Average Basic & Diluted Shares Outstanding	293.06M	291.76M	287.33M	285.60M	285.10M	284.06M	283.50M	283.50M	282.60M	282.43M	281.93M

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Net Change in Cash & Equivalents	-1,025	286	391	-432	-866	59	43	-434	537	-261	459
Net Cash From Operating Activities	512	793	889	1,087	1,021	921	1,485	1,312	1,772	1,751	1,559
Net Cash From Continuing Operating Activities	512	793	889	1,087	1,021	921	1,485	1,312	1,772	1,751	1,559
Net Income / (Loss) Continuing Operations	401	462	684	316	1,071	719	1,210	1,254	1,240	1,289	1,303
Consolidated Net Income / (Loss)	401	462	684	316	1,071	719	1,210	1,254	1,240	1,289	1,303
Depreciation Expense	253	246	212	210	238	308	321	317	271	257	288
Non-Cash Adjustments To Reconcile Net Income	103	112	91	106	97	191	63	236	432	186	229
Changes in Operating Assets and Liabilities, net	-245	-27	-98	455	-385	-297	-109	-495	-171	19	-261
Net Cash From Investing Activities	-400	-238	-304	-705	-1,590	-147	-749	-338	-310	-1,258	-394
Net Cash From Continuing Investing Activities	-400	-238	-304	-705	-1,590	-147	-749	-338	-310	-1,258	-394
Purchase of Property, Plant & Equipment	-98	-139	-176	-177	-155	-119	-188	-291	-298	-378	-407
Acquisitions	-75	-261	-128	-516	-1,409	0.00	-547	-52	-51	-862	4.00
Purchase of Investments	0.00	-80	-1.00	-11	-23	-20	-22	-13	-	-5.00	0.00
Sale of Property, Plant & Equipment	12	0.00	0.00	1.00	0.00	1.00	1.00	0.00	4.00	0.00	2.00
Divestitures	3.00	0.00	2.00	-	-	-	0.00	0.00	50	0.00	0.00
Sale and/or Maturity of Investments	0.00	1.00	-	-	0.00	0.00	12	22	5.00	0.00	8.00
Other Investing Activities, net	-242	241	-1.00	-2.00	-3.00	-9.00	-5.00	-4.00	-20	-13	-1.00
Net Cash From Financing Activities	-1,089	-268	-202	-797	-299	-717	-696	-1,372	-930	-752	-715
Net Cash From Continuing Financing Activities	-1,089	-268	-202	-797	-299	-717	-696	-1,372	-930	-752	-715
Repayment of Debt	0.00	-294	-290	-693	-706	-1,766	-424	-609	-35	-569	-45
Repurchase of Common Equity	-267	-434	-194	-422	-723	-469	-788	-1,139	-575	-1,153	-435
Payment of Dividends	-133	-150	-170	-191	-210	-222	-236	-250	-265	-274	-282
Issuance of Debt	0.00	554	400	483	1,302	1,717	773	635	0.00	1,197	4.00
Issuance of Common Equity	58	62	66	56	54	60	55	58	67	77	72
Other Financing Activities, net	-747	-6.00	-14	-30	-16	-37	-76	-67	-122	-30	-29
Other Net Changes in Cash	-	-	-	-	-	-	-	-	5.00	-2.00	9.00
Cash Interest Paid	71	73	82	80	80	71	76	85	89	80	101
Cash Income Taxes Paid	129	67	63	102	159	361	211	279	199	314	318

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026	7/31/2026
Net Change in Cash & Equivalents	157	-76	108	-450	138	19	48	254	-31	49	-49
Net Cash From Operating Activities	485	333	452	481	431	221	362	545	268	277	519
Net Cash From Continuing Operating Activities	485	333	452	481	431	221	362	545	268	277	519
Net Income / (Loss) Continuing Operations	348	308	282	351	318	215	336	434	305	339	362
Consolidated Net Income / (Loss)	348	308	282	351	318	215	336	434	305	339	362
Depreciation Expense	62	63	63	69	72	73	72	71	67	67	66
Non-Cash Adjustments To Reconcile Net Income	54	44	42	46	49	87	43	50	51	50	53
Changes in Operating Assets and Liabilities, net	21	-82	65	15	-8.00	-154	-89	-10	-155	-179	38
Net Cash From Investing Activities	-95	-109	-100	-954	-94	-114	-96	-90	-93	-77	-1,032
Net Cash From Continuing Investing Activities	-95	-109	-100	-954	-94	-114	-96	-90	-93	-77	-1,032
Purchase of Property, Plant & Equipment	-90	-103	-92	-93	-97	-114	-103	-93	-93	-76	-80
Acquisitions	0.00	-	-3.00	-859	4.00	-	-	-	0.00	-	-950
Other Investing Activities, net	-5.00	-3.00	-3.00	-2.00	-1.00	-	-	-	0.00	-1.00	-2.00
Net Cash From Financing Activities	-240	-291	-246	25	-180	-116	-219	-200	-222	-144	471
Net Cash From Continuing Financing Activities	-240	-291	-246	28	-180	-116	-219	-200	-222	-144	471
Repayment of Debt	-180	-	-	-429	-31	130	-88	-56	-2.00	-3.00	-8.00
Repurchase of Common Equity	0.00	-230	-585	-335	-90	-175	-85	-85	-152	-68	-78
Payment of Dividends	-69	-69	-68	-68	-71	-70	-71	-70	-72	-72	-72
Issuance of Debt	0.00	-	375	862	4.00	-	-	-	0.00	-	600
Issuance of Common Equity	34	9.00	33	1.00	30	1.00	29	12	31	1.00	31
Other Financing Activities, net	-25	-1.00	-1.00	-3.00	-22	-2.00	-4.00	-1.00	-27	-2.00	-2.00
Other Net Changes in Cash	7.00	-	-	-	-19	28	1.00	-1.00	16	-7.00	-7.00
Cash Interest Paid	14	26	10	30	3.00	48	4.00	46	1.00	44	2.00
Cash Income Taxes Paid	24	200	60	30	19	229	56	14	105	215	56

This table presents Agilent Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Total Assets	7,479	7,794	8,426	8,541	9,452	9,627	10,705	10,532	10,763	11,846	12,727
Total Current Assets	3,686	3,635	4,169	3,848	3,189	3,415	3,799	3,778	4,186	3,959	4,594
Cash & Equivalents	2,003	2,289	2,678	2,247	1,382	1,441	1,484	1,053	1,590	1,329	1,789
Accounts Receivable	606	631	724	776	930	1,038	1,172	1,405	1,291	1,324	1,487
Inventories, net	541	533	575	638	679	720	830	1,038	1,031	972	1,025
Other Current Assets	294	182	192	187	198	216	222	282	274	334	293
Plant, Property, & Equipment, net	604	639	757	822	850	845	945	1,100	1,270	1,778	2,023
Total Noncurrent Assets	3,189	3,520	3,500	3,871	5,413	5,367	5,961	5,654	5,307	6,109	6,110
Long-Term Investments	86	135	138	68	102	158	185	195	164	175	133
Goodwill	2,366	2,517	2,607	2,973	3,593	3,602	3,975	3,952	3,960	4,477	4,473
Intangible Assets	445	416	361	491	1,107	831	981	821	475	547	445
Other Noncurrent Operating Assets	292	452	394	339	611	776	820	686	708	910	1,059
Total Liabilities & Shareholders' Equity	7,479	7,794	8,426	8,541	9,452	9,627	10,705	10,532	10,763	11,846	12,727
Total Liabilities	3,309	3,548	3,591	3,970	4,704	4,754	5,316	5,227	4,918	5,948	5,986
Total Current Liabilities	976	945	1,263	1,171	2,080	1,467	1,708	1,861	1,603	1,895	2,347
Short-Term Debt	-	0.00	210	0.00	616	75	0.00	36	0.00	45	304
Accounts Payable	279	257	305	340	354	354	446	580	418	540	570
Accrued Expenses	-	-	-	-	-	-	-	-	-	-	406
Current Deferred Revenue	258	269	291	324	336	386	441	461	505	544	624
Current Employee Benefit Liabilities	221	235	276	304	334	367	493	455	371	368	443
Total Noncurrent Liabilities	2,333	2,603	2,328	2,799	2,624	3,287	3,608	3,366	3,315	4,053	3,639
Long-Term Debt	1,655	1,904	1,801	1,799	1,791	2,284	2,729	2,733	2,735	3,345	3,050
Noncurrent Employee Benefit Liabilities	264	360	234	239	360	389	220	97	103	130	126
Other Noncurrent Operating Liabilities	414	339	293	761	473	614	659	536	477	578	463
Commitments & Contingencies	-	-	-	-	0.00	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,170	4,246	4,835	4,571	4,748	4,873	5,389	5,305	5,845	5,898	6,741
Total Preferred & Common Equity	4,167	4,243	4,831	4,567	4,748	4,873	5,389	5,305	5,845	5,898	6,741
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,167	4,243	4,831	4,567	4,748	4,873	5,389	5,305	5,845	5,898	6,741
Common Stock	9,051	9,165	5,303	5,311	5,280	5,314	5,323	5,328	5,390	5,453	5,578
Retained Earnings	5,581	6,089	-126	-336	-18	81	348	324	782	750	1,389
Accumulated Other Comprehensive Income / (Loss)	-391	-503	-346	-408	-514	-522	-282	-347	-327	-305	-226

This table presents Agilent Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	1/31/2026	4/30/2026	7/31/2026
Total Assets	10,763	10,948	10,856	10,996	11,846	11,914	12,158	12,226	12,813	13,065	13,967
Total Current Assets	4,186	4,338	4,203	4,256	3,959	4,107	4,208	4,253	4,615	4,763	4,693
Cash & Equivalents	1,590	1,748	1,671	1,779	1,329	1,467	1,486	1,535	1,758	1,807	1,758
Accounts Receivable	1,291	1,295	1,249	1,227	1,324	1,328	1,366	1,382	1,521	1,498	1,478
Inventories, net	1,031	1,033	1,000	978	972	997	991	1,014	1,059	1,089	1,117
Other Current Assets	274	262	283	272	334	315	365	322	277	369	340
Plant, Property, & Equipment, net	1,270	1,314	1,371	1,446	1,778	1,816	1,912	1,966	2,078	2,099	2,134
Total Noncurrent Assets	5,307	5,296	5,282	5,294	6,109	5,991	6,038	6,007	6,120	6,203	7,140
Long-Term Investments	164	170	177	186	175	173	135	133	135	136	130
Goodwill	3,960	3,967	3,963	3,965	4,477	4,429	4,474	4,475	4,484	4,484	5,030
Intangible Assets	475	443	417	392	547	514	495	469	426	407	906
Other Noncurrent Operating Assets	708	716	725	751	910	875	934	930	1,075	1,176	1,074
Total Liabilities & Shareholders' Equity	10,763	10,948	10,856	10,996	11,846	11,914	12,158	12,226	12,813	13,065	13,967
Total Liabilities	4,918	4,760	4,642	5,093	5,948	5,887	6,022	5,856	5,905	5,943	6,604
Total Current Liabilities	1,603	1,617	1,958	2,389	1,895	1,869	2,012	1,892	2,234	2,269	2,289
Short-Term Debt	0.00	-	420	795	45	16	146	59	304	304	304
Accounts Payable	418	488	461	497	540	547	517	530	602	615	608
Accrued Expenses	-	335	218	264	398	436	374	337	349	298	314
Current Deferred Revenue	505	522	533	524	544	612	628	620	682	665	640
Current Employee Benefit Liabilities	371	272	326	309	368	258	347	346	297	387	423
Total Noncurrent Liabilities	3,315	3,143	2,684	2,704	4,053	4,018	4,010	3,964	3,671	3,674	4,315
Long-Term Debt	2,735	2,555	2,136	2,137	3,345	3,347	3,349	3,350	3,050	3,051	3,645
Noncurrent Employee Benefit Liabilities	103	102	99	96	130	120	126	119	130	127	128
Other Noncurrent Operating Liabilities	477	486	449	471	578	551	535	495	491	496	542
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,845	6,188	6,214	5,903	5,898	6,027	6,136	6,370	6,908	7,122	7,363
Total Preferred & Common Equity	5,845	6,188	6,214	5,903	5,898	6,027	6,136	6,370	6,908	7,122	7,363
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,845	6,188	6,214	5,903	5,898	6,027	6,136	6,370	6,908	7,122	7,363
Common Stock	5,390	5,443	5,461	5,461	5,453	5,492	5,504	5,551	5,608	5,632	5,684
Retained Earnings	782	1,061	1,090	773	750	916	912	1,102	1,484	1,692	1,912
Accumulated Other Comprehensive Income / (Loss)	-327	-316	-337	-331	-305	-381	-280	-283	-184	-202	-233

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.25%	4.06%	6.43%	9.88%	5.07%	3.41%	18.36%	8.37%	-0.22%	-4.73%	6.73%
EBITDA Growth	14.45%	7.45%	25.97%	11.29%	0.17%	2.09%	44.26%	7.73%	-12.76%	8.46%	-1.17%
EBIT Growth	63.33%	12.24%	42.15%	14.30%	-2.65%	-4.70%	57.79%	9.73%	-12.41%	11.14%	-3.38%
NOPAT Growth	12.21%	9.65%	31.61%	-56.07%	263.16%	-34.12%	65.89%	12.57%	-7.33%	0.87%	6.50%
Net Income Growth	-26.96%	15.21%	48.05%	-53.80%	238.92%	-32.87%	68.29%	3.64%	-1.12%	3.95%	1.09%
EPS Growth	-25.93%	16.67%	50.00%	-53.81%	247.42%	-31.75%	71.30%	6.09%	0.24%	5.73%	3.16%
Operating Cash Flow Growth	-29.96%	54.88%	12.11%	22.27%	-6.07%	-9.79%	61.24%	-11.65%	35.06%	-1.19%	-10.97%
Free Cash Flow Firm Growth	-62.10%	-59.07%	32.07%	-27.76%	-287.52%	246.41%	-37.74%	86.10%	41.90%	-75.76%	214.80%
Invested Capital Growth	-6.25%	6.64%	8.16%	0.62%	39.85%	-0.67%	12.87%	7.36%	0.00%	14.03%	5.00%
Revenue Q/Q Growth	-0.20%	1.84%	1.78%	2.18%	1.43%	2.22%	2.88%	2.84%	-2.30%	0.20%	2.36%
EBITDA Q/Q Growth	18.92%	0.59%	6.77%	1.45%	1.19%	4.72%	11.04%	-0.32%	-3.44%	-0.50%	2.60%
EBIT Q/Q Growth	41.84%	1.51%	9.14%	1.34%	-0.62%	6.42%	13.13%	0.32%	-3.35%	-1.03%	2.98%
NOPAT Q/Q Growth	12.46%	0.02%	-0.05%	9.47%	1.97%	3.63%	15.64%	-1.38%	7.30%	-7.64%	6.27%
Net Income Q/Q Growth	21.88%	-2.94%	8.06%	6.04%	-0.09%	4.05%	22.22%	-5.57%	9.44%	-8.78%	6.80%
EPS Q/Q Growth	21.21%	-4.11%	6.60%	6.59%	0.90%	3.60%	23.13%	-4.78%	9.40%	-7.71%	7.03%
Operating Cash Flow Q/Q Growth	12.53%	-0.88%	6.47%	8.37%	-5.38%	7.34%	4.50%	0.54%	3.99%	-1.96%	4.28%
Free Cash Flow Firm Q/Q Growth	-66.64%	20.37%	-33.29%	171.96%	-192.67%	281.10%	-28.53%	9.05%	16.93%	-77.10%	4,091.55%
Invested Capital Q/Q Growth	-2.89%	-3.94%	0.95%	-2.66%	21.15%	-2.85%	3.01%	1.40%	-0.03%	13.30%	0.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.54%	52.28%	53.64%	54.54%	54.33%	53.14%	53.92%	54.35%	50.71%	54.30%	52.43%
EBITDA Margin	19.61%	20.25%	23.97%	24.28%	23.15%	22.85%	27.85%	27.69%	24.21%	27.56%	25.52%
Operating Margin	12.93%	14.64%	18.05%	18.40%	18.23%	15.85%	21.32%	23.63%	19.76%	22.86%	21.29%
EBIT Margin	13.35%	14.40%	19.23%	20.00%	18.54%	17.08%	22.77%	23.06%	20.24%	23.61%	21.37%
Profit (Net Income) Margin	9.93%	10.99%	15.30%	6.43%	20.74%	13.47%	19.15%	18.31%	18.15%	19.80%	18.75%
Tax Burden Percent	83.54%	84.93%	85.18%	33.40%	116.54%	85.39%	88.97%	83.38%	92.61%	84.75%	90.80%
Interest Burden Percent	89.05%	89.92%	93.37%	96.24%	96.03%	92.32%	94.51%	95.25%	96.82%	98.96%	96.63%
Effective Tax Rate	8.75%	15.07%	14.82%	66.60%	-16.54%	14.61%	11.03%	16.62%	7.39%	15.25%	9.20%
Return on Invested Capital (ROIC)	13.19%	14.47%	17.73%	7.47%	22.55%	12.78%	19.99%	20.47%	18.32%	17.26%	16.83%
ROIC Less NNEP Spread (ROIC-NNEP)	19.88%	24.55%	18.24%	5.35%	9.95%	12.38%	21.33%	12.83%	17.50%	19.21%	14.42%
Return on Net Nonoperating Assets (RNNOA)	-4.73%	-3.49%	-2.66%	-0.75%	0.43%	2.16%	3.59%	2.99%	3.93%	4.69%	3.79%
Return on Equity (ROE)	8.47%	10.98%	15.06%	6.72%	22.99%	14.95%	23.58%	23.45%	22.24%	21.95%	20.62%
Cash Return on Invested Capital (CROIC)	19.65%	8.04%	9.89%	6.85%	-10.68%	13.45%	7.90%	13.37%	18.32%	4.15%	11.96%
Operating Return on Assets (OROA)	5.89%	7.92%	10.60%	11.59%	10.64%	9.56%	14.16%	14.87%	12.99%	13.60%	12.09%
Return on Assets (ROA)	4.38%	6.05%	8.43%	3.72%	11.90%	7.54%	11.90%	11.81%	11.65%	11.40%	10.61%
Return on Common Equity (ROCE)	8.46%	10.97%	15.05%	6.71%	22.98%	14.95%	23.58%	23.45%	22.24%	21.95%	20.62%
Return on Equity Simple (ROE_SIMPLE)	9.62%	10.89%	14.16%	6.92%	22.56%	14.75%	22.45%	23.64%	21.21%	21.85%	0.00%
Net Operating Profit after Tax (NOPAT)	476	522	687	302	1,097	722	1,198	1,349	1,250	1,261	1,343
NOPAT Margin	11.80%	12.43%	15.37%	6.15%	21.24%	13.53%	18.97%	19.70%	18.30%	19.37%	19.33%
Net Nonoperating Expense Percent (NNEP)	-6.69%	-10.08%	-0.51%	2.12%	12.60%	0.41%	-1.34%	7.63%	0.81%	-1.95%	2.41%
Return On Investment Capital (ROIC_SIMPLE)	8.18%	8.49%	10.04%	4.74%	15.33%	9.99%	14.76%	16.71%	14.57%	13.58%	13.30%
Cost of Revenue to Revenue	49.46%	47.72%	46.36%	45.46%	45.67%	46.86%	46.08%	45.65%	49.29%	45.70%	47.57%
SG&A Expenses to Revenue	29.45%	29.82%	27.97%	28.27%	28.28%	28.02%	25.62%	23.90%	23.91%	24.09%	24.60%
R&D to Revenue	8.17%	7.83%	7.63%	7.88%	7.82%	9.27%	6.98%	6.82%	7.04%	7.36%	6.55%
Operating Expenses to Revenue	37.62%	37.65%	35.60%	36.14%	36.10%	37.29%	32.60%	30.72%	30.95%	31.44%	31.15%
Earnings before Interest and Taxes (EBIT)	539	605	860	983	957	912	1,439	1,579	1,383	1,537	1,485
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	792	851	1,072	1,193	1,195	1,220	1,760	1,896	1,654	1,794	1,773
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.79	3.13	4.29	4.32	4.76	6.28	8.65	7.60	5.13	6.34	6.16
Price to Tangible Book Value (P/TBV)	8.57	10.12	11.13	17.90	470.97	69.58	107.71	75.79	21.27	42.76	22.76
Price to Revenue (P/Rev)	2.88	3.16	4.64	4.02	4.38	5.73	7.38	5.89	4.39	5.74	5.97
Price to Earnings (P/E)	28.97	28.70	30.32	62.47	21.11	42.58	38.54	32.15	24.18	28.99	31.84
Dividend Yield	1.14%	1.13%	0.82%	0.96%	0.90%	0.73%	0.50%	0.62%	0.88%	0.73%	0.68%
Earnings Yield	3.45%	3.48%	3.30%	1.60%	4.74%	2.35%	2.59%	3.11%	4.14%	3.45%	3.14%
Enterprise Value to Invested Capital (EV/IC)	3.13	3.42	4.95	4.74	4.15	5.57	7.49	6.13	4.54	5.04	5.25
Enterprise Value to Revenue (EV/Rev)	2.71	3.03	4.46	3.91	4.56	5.88	7.53	6.11	4.53	6.03	6.18
Enterprise Value to EBITDA (EV/EBITDA)	13.82	14.97	18.60	16.12	19.69	25.72	27.05	22.07	18.72	21.88	24.21
Enterprise Value to EBIT (EV/EBIT)	20.30	21.06	23.19	19.56	24.59	34.40	33.08	26.50	22.39	25.54	28.91
Enterprise Value to NOPAT (EV/NOPAT)	22.97	24.40	29.01	63.68	21.46	43.43	39.72	31.02	24.77	31.13	31.96
Enterprise Value to Operating Cash Flow (EV/OCF)	21.37	16.07	22.43	17.69	23.05	34.07	32.06	31.89	17.48	22.42	27.53
Enterprise Value to Free Cash Flow (EV/FCFF)	15.43	43.90	52.01	69.43	0.00	41.26	100.55	47.49	24.77	129.55	45.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.40	0.45	0.42	0.39	0.51	0.48	0.51	0.52	0.47	0.57	0.50
Long-Term Debt to Equity	0.40	0.45	0.37	0.39	0.38	0.47	0.51	0.52	0.47	0.57	0.45
Financial Leverage	-0.24	-0.14	-0.15	-0.14	0.04	0.17	0.17	0.23	0.22	0.24	0.26
Leverage Ratio	1.93	1.81	1.79	1.80	1.93	1.98	1.98	1.99	1.91	1.93	1.94
Compound Leverage Factor	1.72	1.63	1.67	1.74	1.85	1.83	1.87	1.89	1.85	1.91	1.88
Debt to Total Capital	28.41%	30.96%	29.37%	28.24%	33.64%	32.62%	33.62%	34.30%	31.88%	36.50%	33.22%
Short-Term Debt to Total Capital	0.00%	0.00%	3.07%	0.00%	8.61%	1.04%	0.00%	0.45%	0.00%	0.48%	3.01%
Long-Term Debt to Total Capital	28.41%	30.96%	26.31%	28.24%	25.03%	31.58%	33.62%	33.85%	31.88%	36.01%	30.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.05%	0.05%	0.06%	0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	71.54%	68.99%	70.57%	71.70%	66.36%	67.38%	66.38%	65.70%	68.12%	63.50%	66.78%
Debt to EBITDA	2.09	2.24	1.88	1.51	2.01	1.93	1.55	1.46	1.65	1.89	1.89
Net Debt to EBITDA	-0.85	-0.61	-0.75	-0.43	0.77	0.62	0.55	0.80	0.59	1.05	0.81
Long-Term Debt to EBITDA	2.09	2.24	1.68	1.51	1.50	1.87	1.55	1.44	1.65	1.86	1.72
Debt to NOPAT	3.47	3.65	2.93	5.96	2.19	3.27	2.28	2.05	2.19	2.69	2.50
Net Debt to NOPAT	-1.42	-1.00	-1.17	-1.71	0.84	1.05	0.81	1.13	0.78	1.50	1.07
Long-Term Debt to NOPAT	3.47	3.65	2.62	5.96	1.63	3.16	2.28	2.03	2.19	2.65	2.27
Altman Z-Score	4.36	4.55	4.73	4.26	3.90	4.99	6.58	6.03	5.11	5.05	5.45
Noncontrolling Interest Sharing Ratio	0.06%	0.07%	0.08%	0.09%	0.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.78	3.85	3.30	3.29	1.53	2.33	2.22	2.03	2.61	2.09	1.96
Quick Ratio	2.67	3.09	2.69	2.58	1.11	1.69	1.61	1.32	1.80	1.40	1.40
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	709	290	383	277	-519	760	473	881	1,250	303	954
Operating Cash Flow to CapEx	595.35%	570.50%	505.11%	617.61%	658.71%	780.51%	794.12%	450.86%	602.72%	463.23%	384.94%
Free Cash Flow to Firm to Interest Expense	10.75	4.03	4.85	3.69	-7.02	9.75	5.84	10.49	13.16	3.16	8.52
Operating Cash Flow to Interest Expense	7.76	11.01	11.25	14.49	13.80	11.81	18.33	15.62	18.65	18.24	13.92
Operating Cash Flow Less CapEx to Interest Expense	6.45	9.08	9.03	12.15	11.70	10.29	16.02	12.15	15.56	14.30	10.30
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.44	0.55	0.55	0.58	0.57	0.56	0.62	0.64	0.64	0.58	0.57
Accounts Receivable Turnover	6.56	6.79	6.60	6.55	6.05	5.43	5.72	5.31	5.07	4.98	4.94
Inventory Turnover	3.58	3.73	3.74	3.68	3.58	3.58	3.76	3.35	3.26	2.97	3.31
Fixed Asset Turnover	6.54	6.76	6.41	6.22	6.18	6.30	7.06	6.70	5.77	4.27	3.66
Accounts Payable Turnover	6.87	7.48	7.38	6.93	6.80	7.07	7.28	6.09	6.75	6.21	5.96
Days Sales Outstanding (DSO)	55.68	53.73	55.30	55.71	60.30	67.27	63.83	68.68	72.01	73.31	73.84
Days Inventory Outstanding (DIO)	101.90	97.76	97.54	99.09	101.93	102.05	97.14	109.06	112.11	122.87	110.27
Days Payable Outstanding (DPO)	53.10	48.79	49.48	52.69	53.71	51.64	50.14	59.90	54.08	58.77	61.29
Cash Conversion Cycle (CCC)	104.48	102.70	103.36	102.11	108.52	117.67	110.83	117.83	130.04	137.41	122.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,494	3,726	4,030	4,055	5,671	5,633	6,358	6,826	6,826	7,784	8,173
Invested Capital Turnover	1.12	1.16	1.15	1.22	1.06	0.94	1.05	1.04	1.00	0.89	0.87
Increase / (Decrease) in Invested Capital	-233	232	304	25	1,616	-38	725	468	0.00	958	389
Enterprise Value (EV)	10,942	12,743	19,939	19,229	23,530	31,374	47,606	41,842	30,967	39,259	42,925
Market Capitalization	11,615	13,260	20,740	19,741	22,607	30,614	46,637	40,321	29,986	37,373	41,493
Book Value per Share	$12.57	$13.08	$15.01	$14.33	$15.34	$15.81	$17.80	$17.92	$19.98	$20.53	$23.78
Tangible Book Value per Share	$4.09	$4.04	$5.79	$3.46	$0.16	$1.43	$1.43	$1.80	$4.82	$3.04	$6.43
Total Capital	5,825	6,150	6,846	6,370	7,155	7,232	8,118	8,074	8,580	9,288	10,095
Total Debt	1,655	1,904	2,011	1,799	2,407	2,359	2,729	2,769	2,735	3,390	3,354
Total Long-Term Debt	1,655	1,904	1,801	1,799	1,791	2,284	2,729	2,733	2,735	3,345	3,050
Net Debt	-676	-520	-805	-516	923	760	969	1,521	981	1,886	1,432
Capital Expenditures (CapEx)	86	139	176	176	155	118	187	291	294	378	405
Debt-free, Cash-free Net Working Capital (DFCFNWC)	465	401	438	430	343	582	516	900	993	780	762
Debt-free Net Working Capital (DFNWC)	2,710	2,690	3,116	2,677	1,725	2,023	2,091	1,953	2,583	2,109	2,551
Net Working Capital (NWC)	2,710	2,690	2,906	2,677	1,109	1,948	2,091	1,917	2,583	2,064	2,247
Net Nonoperating Expense (NNE)	75	60	3.41	-14	26	3.42	-12	95	10	-28	40
Net Nonoperating Obligations (NNO)	-676	-520	-805	-516	923	760	969	1,521	981	1,886	1,432
Total Depreciation and Amortization (D&A)	253	246	212	210	238	308	321	317	271	257	288
Debt-free, Cash-free Net Working Capital to Revenue	11.52%	9.54%	9.79%	8.75%	6.64%	10.90%	8.17%	13.14%	14.53%	11.98%	10.97%
Debt-free Net Working Capital to Revenue	67.11%	64.02%	69.68%	54.48%	33.41%	37.89%	33.09%	28.52%	37.80%	32.40%	36.72%
Net Working Capital to Revenue	67.11%	64.02%	64.98%	54.48%	21.48%	36.49%	33.09%	27.99%	37.80%	31.71%	32.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.20	$1.42	$2.12	$0.98	$3.41	$2.33	$3.98	$4.19	$4.22	$4.44	$4.59
Adjusted Weighted Average Basic Shares Outstanding	333M	326M	322M	321M	314M	309M	304M	299M	294M	290M	284M
Adjusted Diluted Earnings per Share	$1.20	$1.40	$2.10	$0.97	$3.37	$2.30	$3.94	$4.18	$4.19	$4.43	$4.57
Adjusted Weighted Average Diluted Shares Outstanding	335M	329M	326M	325M	318M	312M	307M	300M	296M	291M	285M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$3.41	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	332.17M	321.75M	323.02M	318.53M	310.18M	306.85M	302.00M	296.07M	293.00M	285.60M	283.50M
Normalized Net Operating Profit after Tax (NOPAT)	476	522	687	633	659	722	1,198	1,349	1,250	1,261	1,343
Normalized NOPAT Margin	11.80%	12.43%	15.37%	12.88%	12.76%	13.53%	18.97%	19.70%	18.30%	19.37%	19.33%
Pre Tax Income Margin	11.89%	12.95%	17.96%	19.25%	17.80%	15.77%	21.52%	21.96%	19.60%	23.36%	20.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.17	8.40	10.89	13.11	12.93	11.69	17.77	18.80	14.56	16.01	13.26
NOPAT to Interest Expense	7.22	7.25	8.70	4.03	14.82	9.26	14.80	16.06	13.16	13.14	11.99
EBIT Less CapEx to Interest Expense	6.86	6.47	8.66	10.76	10.84	10.18	15.46	15.33	11.46	12.07	9.64
NOPAT Less CapEx to Interest Expense	5.91	5.32	6.47	1.68	12.72	7.75	12.49	12.60	10.07	9.20	8.37
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	33.17%	32.47%	24.85%	60.44%	19.61%	30.88%	19.50%	19.94%	21.37%	21.26%	21.64%
Augmented Payout Ratio	99.75%	126.41%	53.22%	193.99%	87.11%	96.11%	84.63%	110.77%	67.74%	110.47%	55.03%

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026	7/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	283,498,871.00	282,602,317.00	282,431,944.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	283,498,871.00	282,602,317.00	282,431,944.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	1.08	1.20	1.28
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.58%	-8.39%	-5.62%	0.77%	1.39%	6.04%	10.14%	9.41%	-	10.01%	8.06%
EBITDA Growth	-4.87%	-4.78%	91.12%	-1.85%	-3.62%	-20.55%	10.02%	9.41%	-	39.94%	16.44%
EBIT Growth	-4.46%	-3.60%	141.96%	-3.76%	-6.63%	-26.67%	9.25%	10.51%	-	52.73%	21.16%
NOPAT Growth	-9.34%	-2.56%	144.79%	-22.60%	-1.75%	-17.01%	20.72%	21.80%	-	33.64%	9.53%
Net Income Growth	-1.14%	1.99%	154.05%	-26.11%	-8.62%	-30.19%	19.15%	23.65%	-	57.67%	7.74%
EPS Growth	-0.84%	2.94%	155.26%	-23.13%	-5.93%	-28.57%	21.65%	24.39%	-	60.00%	8.47%
Operating Cash Flow Growth	63.85%	-16.33%	-19.57%	-6.78%	-11.13%	-33.63%	-19.91%	13.31%	-	25.34%	43.37%
Free Cash Flow Firm Growth	368.83%	345.12%	1,363.16%	-230.22%	-192.38%	-258.49%	-492.84%	107.65%	-	77.08%	-4.45%
Invested Capital Growth	-4.44%	-3.23%	0.62%	14.03%	13.55%	15.72%	18.06%	5.00%	-	6.54%	16.19%
Revenue Q/Q Growth	-1.78%	-5.13%	0.32%	7.79%	-1.18%	-0.77%	4.20%	7.08%	-	2.06%	2.34%
EBITDA Q/Q Growth	-3.70%	-6.61%	-6.62%	16.87%	-5.44%	-23.01%	29.31%	16.22%	-	10.43%	7.60%
EBIT Q/Q Growth	-4.24%	-7.86%	-7.73%	18.21%	-7.09%	-27.63%	37.45%	19.58%	-	12.30%	9.05%
NOPAT Q/Q Growth	-28.14%	-9.85%	-8.42%	30.44%	-8.77%	-23.86%	33.22%	31.62%	-	12.08%	9.19%
Net Income Q/Q Growth	-26.74%	-11.49%	-8.44%	24.47%	-9.40%	-32.39%	56.28%	29.17%	-	11.15%	6.78%
EPS Q/Q Growth	-26.25%	-11.02%	-7.62%	26.80%	-9.76%	-32.43%	57.33%	29.66%	-	12.15%	6.67%
Operating Cash Flow Q/Q Growth	-6.01%	-31.34%	35.74%	6.42%	-10.40%	-48.72%	63.80%	50.55%	-	3.36%	87.36%
Free Cash Flow Firm Q/Q Growth	40.56%	-18.29%	-56.26%	-359.24%	0.28%	-40.17%	-8.40%	105.05%	-	40.45%	-394.08%
Invested Capital Q/Q Growth	-0.01%	1.42%	-0.75%	13.30%	-0.44%	3.35%	1.26%	0.76%	-	1.97%	10.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.76%	54.42%	54.18%	53.85%	53.48%	51.92%	51.09%	53.20%	-	53.95%	55.48%
EBITDA Margin	28.29%	27.84%	25.92%	28.10%	26.89%	20.86%	25.89%	28.10%	-	26.54%	27.90%
Operating Margin	23.16%	23.08%	21.10%	23.99%	22.37%	17.99%	20.71%	23.80%	-	21.74%	23.64%
EBIT Margin	24.55%	23.84%	21.93%	24.04%	22.61%	16.49%	21.75%	24.29%	-	22.89%	24.39%
Profit (Net Income) Margin	20.99%	19.58%	17.87%	20.63%	18.92%	12.89%	19.33%	23.32%	-	18.47%	19.28%
Tax Burden Percent	86.35%	82.35%	82.22%	87.53%	86.65%	82.69%	91.80%	98.19%	-	83.09%	81.53%
Interest Burden Percent	99.02%	99.73%	99.13%	98.04%	96.58%	94.55%	96.83%	97.79%	-	97.14%	96.94%
Effective Tax Rate	13.65%	17.65%	17.78%	12.47%	13.35%	17.31%	8.20%	1.81%	-	16.91%	18.47%
Return on Invested Capital (ROIC)	19.29%	17.80%	16.46%	18.71%	17.37%	13.20%	17.23%	20.35%	-	15.80%	16.21%
ROIC Less NNEP Spread (ROIC-NNEP)	20.80%	18.67%	17.19%	18.28%	16.71%	10.64%	17.64%	20.30%	-	16.25%	16.21%
Return on Net Nonoperating Assets (RNNOA)	3.83%	3.24%	3.36%	4.46%	3.23%	2.22%	3.89%	5.33%	-	4.03%	4.49%
Return on Equity (ROE)	23.11%	21.04%	19.81%	23.17%	20.60%	15.43%	21.12%	25.68%	-	19.82%	20.69%
Cash Return on Invested Capital (CROIC)	21.92%	20.39%	19.32%	4.15%	4.53%	1.57%	0.30%	11.96%	-	10.49%	1.26%
Operating Return on Assets (OROA)	15.12%	14.52%	13.15%	13.85%	12.92%	9.50%	12.71%	13.73%	-	13.13%	13.73%
Return on Assets (ROA)	12.93%	11.92%	10.72%	11.88%	10.81%	7.42%	11.30%	13.19%	-	10.59%	10.85%
Return on Common Equity (ROCE)	23.11%	21.04%	19.81%	23.17%	20.60%	15.43%	21.12%	25.68%	-	19.82%	20.69%
Return on Equity Simple (ROE_SIMPLE)	19.97%	19.99%	23.94%	0.00%	20.89%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	332	299	274	357	326	248	330	435	296	332	362
NOPAT Margin	20.00%	19.00%	17.35%	21.00%	19.38%	14.87%	19.02%	23.37%	-	18.07%	19.28%
Net Nonoperating Expense Percent (NNEP)	-1.51%	-0.87%	-0.74%	0.43%	0.66%	2.56%	-0.41%	0.06%	-	-0.46%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	3.79%	3.41%	3.10%	3.85%	3.47%	2.58%	3.38%	4.31%	2.88%	3.16%	3.20%
Cost of Revenue to Revenue	45.24%	45.58%	45.82%	46.15%	46.52%	48.08%	48.91%	46.80%	-	46.05%	44.52%
SG&A Expenses to Revenue	23.88%	24.16%	25.03%	23.34%	24.39%	27.22%	23.99%	23.00%	-	25.34%	25.29%
R&D to Revenue	7.72%	7.18%	8.05%	6.53%	6.72%	6.71%	6.39%	6.39%	-	6.87%	6.55%
Operating Expenses to Revenue	31.60%	31.34%	33.08%	29.86%	31.11%	33.93%	30.38%	29.39%	-	32.21%	31.84%
Earnings before Interest and Taxes (EBIT)	407	375	346	409	380	275	378	452	374	420	458
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	469	438	409	478	452	348	450	523	441	487	524
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.11	6.43	6.96	6.34	7.16	4.99	5.12	6.16	-	4.59	5.31
Price to Tangible Book Value (P/TBV)	21.26	21.78	26.59	42.76	39.84	26.23	22.87	22.76	-	14.64	27.39
Price to Revenue (P/Rev)	5.61	6.06	6.33	5.74	6.61	4.62	4.80	5.97	-	4.52	5.30
Price to Earnings (P/E)	30.59	32.16	29.10	28.99	34.30	26.25	26.73	31.84	-	23.09	27.14
Dividend Yield	0.71%	0.68%	0.66%	0.73%	0.63%	0.90%	0.85%	0.68%	-	0.87%	0.73%
Earnings Yield	3.27%	3.11%	3.44%	3.45%	2.92%	3.81%	3.74%	3.14%	-	4.33%	3.68%
Enterprise Value to Invested Capital (EV/IC)	5.63	5.87	6.13	5.04	5.79	4.06	4.24	5.25	-	3.99	4.37
Enterprise Value to Revenue (EV/Rev)	5.71	6.17	6.48	6.03	6.87	4.90	5.06	6.18	-	4.71	5.58
Enterprise Value to EBITDA (EV/EBITDA)	23.58	25.28	23.34	21.88	25.27	19.26	19.88	24.21	-	17.92	20.83
Enterprise Value to EBIT (EV/EBIT)	28.18	30.12	27.10	25.54	29.74	23.04	23.82	28.91	-	20.98	24.14
Enterprise Value to NOPAT (EV/NOPAT)	31.67	33.78	30.82	31.13	35.79	26.96	27.18	31.96	-	24.48	28.90
Enterprise Value to Operating Cash Flow (EV/OCF)	19.60	21.44	23.56	22.42	26.46	20.50	22.98	27.53	-	23.46	25.57
Enterprise Value to Free Cash Flow (EV/FCFF)	25.11	28.34	31.80	129.55	136.17	277.37	1,509.49	45.00	-	39.26	372.32
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.41	0.41	0.50	0.57	0.56	0.57	0.54	0.50	-	0.47	0.54
Long-Term Debt to Equity	0.41	0.34	0.36	0.57	0.56	0.55	0.53	0.45	-	0.43	0.50
Financial Leverage	0.18	0.17	0.20	0.24	0.19	0.21	0.22	0.26	-	0.25	0.28
Leverage Ratio	1.85	1.80	1.89	1.93	1.87	1.86	1.89	1.94	-	1.90	1.91
Compound Leverage Factor	1.84	1.80	1.87	1.89	1.81	1.76	1.83	1.90	-	1.85	1.85
Debt to Total Capital	29.22%	29.14%	33.19%	36.50%	35.81%	36.29%	34.86%	33.22%	-	32.02%	34.91%
Short-Term Debt to Total Capital	0.00%	4.79%	9.00%	0.48%	0.17%	1.52%	0.60%	3.01%	-	2.90%	2.69%
Long-Term Debt to Total Capital	29.22%	24.36%	24.19%	36.01%	35.64%	34.77%	34.26%	30.21%	-	29.12%	32.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Common Equity to Total Capital	70.78%	70.86%	66.81%	63.50%	64.19%	63.71%	65.14%	66.78%	-	67.98%	65.09%
Debt to EBITDA	1.57	1.59	1.63	1.89	1.89	2.07	1.97	1.89	-	1.76	2.00
Net Debt to EBITDA	0.39	0.44	0.54	1.05	0.97	1.11	1.01	0.81	-	0.74	1.04
Long-Term Debt to EBITDA	1.57	1.33	1.19	1.86	1.88	1.99	1.94	1.72	-	1.60	1.85
Debt to NOPAT	2.11	2.12	2.15	2.69	2.68	2.90	2.70	2.50	-	2.41	2.77
Net Debt to NOPAT	0.52	0.59	0.71	1.50	1.37	1.56	1.38	1.07	-	1.01	1.45
Long-Term Debt to NOPAT	2.11	1.77	1.57	2.65	2.67	2.78	2.65	2.27	-	2.19	2.56
Altman Z-Score	5.94	6.27	5.84	4.73	5.39	3.99	4.36	5.19	-	4.37	4.58
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.68	2.15	1.78	2.09	2.20	2.09	2.25	1.96	-	2.10	2.05
Quick Ratio	1.88	1.49	1.26	1.40	1.50	1.42	1.54	1.40	-	1.46	1.41
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	649	530	232	-601	-599	-840	-911	46	-323	-192	-951
Operating Cash Flow to CapEx	538.89%	323.30%	491.30%	517.20%	444.33%	193.86%	351.46%	586.02%	-	364.47%	648.75%
Free Cash Flow to Firm to Interest Expense	29.48	26.50	10.54	-18.78	-21.40	-28.96	-32.52	1.70	-	-7.70	-32.79
Operating Cash Flow to Interest Expense	22.05	16.65	20.55	15.03	15.39	7.62	12.93	20.19	-	11.08	17.90
Operating Cash Flow Less CapEx to Interest Expense	17.95	11.50	16.36	12.13	11.93	3.69	9.25	16.74	-	8.04	15.14
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.62	0.61	0.60	0.58	0.57	0.58	0.58	0.57	-	0.57	0.56
Accounts Receivable Turnover	4.89	4.97	5.06	4.98	4.98	5.07	5.20	4.94	-	5.05	5.16
Inventory Turnover	3.11	3.09	2.89	2.97	2.96	3.11	3.23	3.31	-	3.29	3.19
Fixed Asset Turnover	5.47	5.16	4.89	4.27	4.17	4.04	3.98	3.66	-	3.61	3.60
Accounts Payable Turnover	6.48	6.92	6.24	6.21	5.81	6.32	6.27	5.96	-	6.04	5.98
Days Sales Outstanding (DSO)	74.63	73.38	72.08	73.31	73.27	72.00	70.14	73.84	-	72.27	70.80
Days Inventory Outstanding (DIO)	117.50	117.95	126.27	122.87	123.20	117.52	112.94	110.27	-	111.06	114.25
Days Payable Outstanding (DPO)	56.34	52.72	58.45	58.77	62.82	57.72	58.23	61.29	-	60.44	61.01
Cash Conversion Cycle (CCC)	135.79	138.60	139.89	137.41	133.66	131.79	124.86	122.81	-	122.89	124.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,825	6,922	6,870	7,784	7,750	8,010	8,111	8,173	8,369	8,534	9,424
Invested Capital Turnover	0.96	0.94	0.95	0.89	0.90	0.89	0.91	0.87	-	0.87	0.84
Increase / (Decrease) in Invested Capital	-317	-231	42	958	925	1,088	1,241	389	619	524	1,313
Enterprise Value (EV)	38,440	40,656	42,080	39,259	44,905	32,487	34,354	42,925	-	34,067	41,141
Market Capitalization	37,803	39,948	41,113	37,373	43,182	30,613	32,613	41,493	-	32,655	39,080
Book Value per Share	$21.12	$21.20	$20.23	$20.53	$21.10	$21.52	$22.42	$23.78	$24.37	$25.20	$26.07
Tangible Book Value per Share	$6.07	$6.26	$5.30	$3.04	$3.80	$4.09	$5.02	$6.43	$7.05	$7.89	$5.05
Total Capital	8,743	8,770	8,835	9,288	9,390	9,631	9,779	10,095	10,262	10,477	11,312
Total Debt	2,555	2,556	2,932	3,390	3,363	3,495	3,409	3,354	3,354	3,355	3,949
Total Long-Term Debt	2,555	2,136	2,137	3,345	3,347	3,349	3,350	3,050	3,050	3,051	3,645
Net Debt	637	708	967	1,886	1,723	1,874	1,741	1,432	1,461	1,412	2,061
Capital Expenditures (CapEx)	90	103	92	93	97	114	103	93	93	76	80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	973	994	883	780	787	856	885	762	927	991	950
Debt-free Net Working Capital (DFNWC)	2,721	2,665	2,662	2,109	2,254	2,342	2,420	2,551	2,685	2,798	2,708
Net Working Capital (NWC)	2,721	2,245	1,867	2,064	2,238	2,196	2,361	2,247	2,381	2,494	2,404
Net Nonoperating Expense (NNE)	-16	-9.06	-8.22	6.13	7.80	33	-5.51	0.98	-9.22	-7.48	0.00
Net Nonoperating Obligations (NNO)	637	708	967	1,886	1,723	1,874	1,741	1,432	1,461	1,412	2,061
Total Depreciation and Amortization (D&A)	62	63	63	69	72	73	72	71	67	67	66
Debt-free, Cash-free Net Working Capital to Revenue	14.45%	15.08%	13.59%	11.98%	12.05%	12.91%	13.04%	10.97%	-	13.70%	12.89%
Debt-free Net Working Capital to Revenue	40.40%	40.43%	40.97%	32.40%	34.50%	35.33%	35.65%	36.72%	-	38.69%	36.73%
Net Working Capital to Revenue	40.40%	34.06%	28.74%	31.71%	34.26%	33.13%	34.78%	32.34%	-	34.49%	32.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.19	$1.05	$0.97	$1.23	$1.12	$0.75	$1.18	$1.54	$1.08	$1.20	$1.28
Adjusted Weighted Average Basic Shares Outstanding	293M	293M	290M	290M	285M	285M	284M	284M	283M	282M	282M
Adjusted Diluted Earnings per Share	$1.18	$1.05	$0.97	$1.23	$1.11	$0.75	$1.18	$1.53	$1.07	$1.20	$1.28
Adjusted Weighted Average Diluted Shares Outstanding	294M	293M	291M	291M	287M	285M	285M	285M	284M	283M	283M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	293.06M	291.76M	287.33M	285.60M	285.10M	284.06M	283.50M	283.50M	282.60M	282.43M	281.93M
Normalized Net Operating Profit after Tax (NOPAT)	332	299	274	357	326	248	330	435	296	332	362
Normalized NOPAT Margin	20.00%	19.00%	17.35%	21.00%	19.38%	14.87%	19.02%	23.37%	-	18.07%	19.28%
Pre Tax Income Margin	24.31%	23.78%	21.74%	23.57%	21.83%	15.59%	21.06%	23.75%	-	22.23%	23.64%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	18.50	18.75	15.73	12.78	13.57	9.48	13.50	16.74	-	16.80	15.79
NOPAT to Interest Expense	15.07	14.95	12.44	11.16	11.64	8.55	11.80	16.11	-	13.26	12.48
EBIT Less CapEx to Interest Expense	14.41	13.60	11.55	9.88	10.11	5.55	9.82	13.30	-	13.76	13.03
NOPAT Less CapEx to Interest Expense	10.98	9.80	8.26	8.25	8.17	4.62	8.12	12.67	-	10.22	9.72
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	21.60%	21.74%	19.25%	21.26%	21.92%	23.76%	22.95%	21.64%	-	20.16%	19.86%
Augmented Payout Ratio	62.06%	73.67%	82.59%	110.47%	120.41%	125.39%	79.10%	55.03%	-	47.74%	46.46%

Financials Breakdown Chart

Key Financial Trends

Agilent Technologies’ latest results show a meaningful improvement in operating momentum. In Q2 2026, revenue increased to $1.84 billion from $1.67 billion in the year-ago quarter, while net income rose to $339 million from $215 million. Operating income increased 33% year over year to $399 million, lifting the operating margin to approximately 21.7% from 18.0%.

Revenue growth has recovered. Quarterly revenue climbed from $1.57 billion in Q2 2024 to $1.84 billion in Q2 2026, including a roughly 10% year-over-year increase in the latest quarter.
Profitability is improving faster than sales. Q2 2026 gross profit rose 14% year over year, while operating income increased 33%. Gross margin improved to approximately 54.0% from 51.9%, suggesting better mix, pricing or operating efficiency.
Earnings per share have strengthened. Diluted EPS increased to $1.20 in Q2 2026 from $0.75 in Q2 2025 and $0.38 in Q3 2023. Weighted average diluted shares have also declined from about 299 million in Q3 2022 to 283 million in Q2 2026.
Agilent continues to generate substantial operating cash flow. Q2 2026 operating cash flow was $277 million, and free cash flow after $76 million of capital spending was approximately $201 million.
Liquidity remains solid. Cash and equivalents reached $1.81 billion in Q2 2026, up from $1.33 billion at the end of fiscal 2024 and $1.07 billion in Q3 2022. Current assets of $4.76 billion exceeded current liabilities of $2.27 billion by a comfortable margin.
Shareholder returns remain a priority. The company returned approximately $140 million through $68 million of share repurchases and $72 million of dividends in Q2 2026. The quarterly dividend per share increased to $0.255 from $0.248 in Q2 2025.
Capital spending is consistent and supports capacity. Quarterly purchases of property, plant and equipment have generally ranged from roughly $57 million to $114 million. Q2 2026 spending of $76 million was below the year-ago period but still represented a meaningful investment in the business.
Cash flow is affected by working-capital movements. Changes in operating assets and liabilities reduced Q2 2026 operating cash flow by $179 million, following similarly negative impacts in recent quarters. This appears manageable given Agilent’s profitability, but it can make quarterly cash generation uneven.
Debt has increased substantially compared with 2022. Total debt was approximately $3.36 billion in Q2 2026, compared with about $2.77 billion in Q4 2022 and $2.91 billion in Q3 2022. Although the company has ample liquidity, net debt was approximately $1.55 billion at the latest quarter-end.
The balance sheet contains a large amount of acquisition-related goodwill. Goodwill and intangible assets totaled approximately $4.89 billion in Q2 2026, or about 37% of total assets. Any impairment of these assets could pressure reported earnings and shareholder equity.

Overall, the statements point to a stronger recent earnings trend, expanding margins and continued cash generation. However, investors should monitor whether the revenue recovery is sustained, whether working-capital needs normalize and whether Agilent can reduce leverage while continuing its dividend and repurchase programs.

09/09/26 11:42 PM ETAI Generated. May Contain Errors.

Agilent Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Agilent Technologies' fiscal year ends in October. Their fiscal year 2025 ended on October 31, 2025.

Agilent Technologies' net income appears to be on an upward trend, with a most recent value of $1.30 billion in 2025, rising from $401 million in 2015. The previous period was $1.29 billion in 2024. Find out what analysts predict for Agilent Technologies in the coming months.

Agilent Technologies' total operating income in 2025 was $1.48 billion, based on the following breakdown:

Total Gross Profit: $3.64 billion
Total Operating Expenses: $2.16 billion

Over the last 10 years, Agilent Technologies' total revenue changed from $4.04 billion in 2015 to $6.95 billion in 2025, a change of 72.1%.

Agilent Technologies' total liabilities were at $5.99 billion at the end of 2025, a 0.6% increase from 2024, and a 80.9% increase since 2015.

In the past 10 years, Agilent Technologies' cash and equivalents has ranged from $1.05 billion in 2022 to $2.68 billion in 2017, and is currently $1.79 billion as of their latest financial filing in 2025.

Over the last 10 years, Agilent Technologies' book value per share changed from 12.57 in 2015 to 23.78 in 2025, a change of 89.1%.

Related Companies

Financial statements for NYSE:A last updated on 9/1/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilent Technologies (A) Financials

Financials Breakdown Chart

Key Financial Trends

Agilent Technologies Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilent Technologies (A) Financials

Annual Income Statements for Agilent Technologies

Quarterly Income Statements for Agilent Technologies

Annual Cash Flow Statements for Agilent Technologies

Quarterly Cash Flow Statements for Agilent Technologies

Annual Balance Sheets for Agilent Technologies

Quarterly Balance Sheets for Agilent Technologies

Annual Metrics And Ratios for Agilent Technologies

Quarterly Metrics And Ratios for Agilent Technologies

Financials Breakdown Chart

Key Financial Trends

Agilent Technologies Financials - Frequently Asked Questions

When does Agilent Technologies' financial year end?

How has Agilent Technologies' net income changed over the last 10 years?

What is Agilent Technologies' operating income?

How has Agilent Technologies' revenue changed over the last 10 years?

How much debt does Agilent Technologies have?

How much cash does Agilent Technologies have?

How has Agilent Technologies' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools